Transparency Market Research (TMR) has published a new report on the breast reconstruction market for the forecast period of 2019–2027. According to the report, the global breast reconstruction market was valued at ~ US$ 1.3 Bn in 2018, and is projected to expand at a CAGR of ~ 5% from 2019 to 2027. Rise in the prevalence of breast cancer, the launch of new products by companies, and the use of silicone breast implants & acellular dermal matrix for breast reconstruction are anticipated to augment the global breast reconstruction market from 2019 to 2027.
Rise in the prevalence of breast cancer, surge in the number of breast reconstruction procedures, and increase in the demand for acellular dermal matrix are expected to drive the global breast reconstruction market from 2019 to 2027.North America and Western Europe are likely to account for dominant shares of the global breast reconstruction market, owing to advancements in research & development and business expansion by various market leaders.However, product recalls in the market are likely to hamper the global breast reconstruction market.Asia Pacific is expected to be a highly lucrative market for breast reconstruction during the forecast period.
- Rise in Prevalence of Breast Cancer to Propel Market
The prevalence of breast cancer among women is increasing. After skin cancer, breast cancer has the highest prevalence among women across the globe. According to the World Cancer Research Fund International, nearly 2 million new cases of breast cancer were reported globally in 2018.Belgium, Luxembourg, and the Netherlands are the top three countries in Europe with the highest rate of breast cancer. According to data provided by the Continuous Update Project Panel of World Cancer Research Fund International, the consumption of alcoholic drinks is one of the primary causes of premenopausal breast cancer.
Request a Sample of Breast Reconstruction Market Report
- Launch of New Products by Players to Augment Market
Leading players in the global breast reconstruction market have launched new products such as silicone-filled breast implants, acellular dermal matrix, and tissue expanders. The usage of acellular dermal matrices in breast reconstruction has increased due to the rise in the awareness about single-stage breast reconstruction.For instance, in September 2018, Mentor Worldwide LLC launched the CPX4 Smooth Breast Tissue Expander in the U.S., thereby expanding the line of CPX4 Breast tissue expanders that can be used in prepectoral and submuscular breast reconstruction.
- Competitive Landscape in Breast Reconstruction Market
The report also provides the profiles of leading players operating in the global breast reconstruction market. These include Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe.